Continuous airborne particle count in the pharmaceutical industrial environment: a fundamentals theoretical review

Authors

  • Eduardo Santos de Oliveira Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, Campus Diadema, Diadema, SP, Brazi https://orcid.org/0009-0006-8964-8066
  • Felipe Rebello Lourenço Department of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, SP, Brazil
  • Leandro Augusto Calixto Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, Campus Diadema, Diadema, SP, Brazil https://orcid.org/0000-0003-1776-7470
  • Richardt Gama Landgraf Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, Campus Diadema, Diadema, SP, Brazil https://orcid.org/0000-0001-7774-7880

DOI:

https://doi.org/10.1590/s2175-97902025e24077

Keywords:

Particle count, Definition of sampling points, Quality control, Risk assessment, environmental monitoring

Abstract

In a pharmaceutical industrial environment, air quality control aims to find contaminations in the environment, which are used as an indicator of possible contamination of the product. Variables can be common quantities such as pressure differential, temperature, and humidity; or more complex quantities such as the number of particles suspended in the air and microbiological contamination. This set of controls in classified areas is called Environmental Monitoring. Monitoring the concentration of suspended particles in the air is detailed in the ISO 14644-2:2015 standard. This standard makes it mandatory for companies that have clean areas to control the number of particles suspended in the air as part of their environmental monitoring program and serves as a guide regarding the amount of concentration accepted for each type of clean area, as well as the classification of the clean room itself (ISO 14644-1). However, many features are not detailed in the ISO standard. The objective of this article was to review the main fundamentals related to particle counting in a pharmaceutical environment and to be used as a start point for professionals and academics starting studies in this area. 

Downloads

Download data is not yet available.

References

Aakash R, Anamika S, Malviya S, Kharia A. Air Quality Matters: A Holistic Strategy and Approach to HVAC System Validation in Pharmaceuticals. Int J Innovative Sci Res Technol. 2024.

ANVISA. Agência Nacional de Vigilância Sanitária. Instrução Normativa- IN Nº 35. 2019a.

ANVISA. Agência Nacional de Vigilância Sanitária. Farmacopeia Brasileira, 6ª ed. 2019b.

Bogdanova Y, Chernykh T, Bukovskaya J. Aspects of microbiological monitoring of the production environment in pharmaceutical and biotechnological manufacturing. Формулы фармации. 2024.

Britto JFB. Projeto básico de salas limpas, Parte 1. Revista SBCC Edição 54. 2012.

Campanella A. Trend Analysis of Total and Viable Particle Monitoring Data and Definition of Alert and Action Limits. Particle Measuring Systems Application Note 261. 2017.

Chen S, Xu Y, Zhao C, Liu X, Li Y, He Q. Air quality indices and cleanroom ventilation equations, and their application in a cleanroom HVAC system, Part one: theoretical considerations. Clean Air and Containment Review. 2019.

Dalmaso G. Without measurement, there is no control of aseptic processes. Particle Measuring Systems Application Note 255. 2019.

Eaton T. Pharmaceutical Cleanroom Classification using ISO 14644-1 and the EU GGMP Annex 1. EJPPS Volume 24 Issue 4. 2019.

Eissa ME. Quantitative Microbial Risk Assessment of Pharmaceutical Products. PDA JPST. 2016.

Gorsky, I. Environmental Monitoring. Principles of Parenteral Solution Validation. 2019.

Gouveia BG, Rijo P, Goncalo TS, Reis CP. Good manufacturing practices for medicinal products for human use. JPBS. 2015.

Hallworth M. Powder Filling: When and Where to Monitor. Particle Measuring Systems Application Note 200. 2020.

Hartigan P. Particle Data Collection and Interpretation for ISO Cleanrooms. Particle Measuring Systems Application Note 233. 2016.

Hartvig NV, Jensen PL, Hansen O. Sampling Plan for Cleanroom Classification with Respect to Airborne Particles. J IEST. 2011.

Lawson LG. Manage Your Risk: Monitoring the Environment of Aseptic Processes. Particle Measuring Systems Application Note 267. 2018.

Ludwig FP, Silva I. Requisitos de área limpa para produção de medicamentos injetáveis na indústria farmacêutica. Pesquisa e Extensão Oswaldo Cruz. 2019.

ISO 14644-1:2015, Cleanrooms and associated controlled environments — Part 1: Classification of air cleanliness by particle concentration. International Organization for Standardization. 2015.

Parental Drug Association (PDA). Technical Report No. 13 (Revised 2014): Fundamentals of an Environmental Monitoring Program. 2014.

Parental Drug Association (PDA). Points to Consider for Aseptic Processing – Part 1. 2015.

Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Guide To Good Manufacturing Practice For Medicinal Products Annexes. 2021.

Particle Measuring Systems (PMS). Microbiological and Particle Risk Assessment of a Cleanroom and Aseptic Filling Line. Particle Measuring Systems Application Note 262. 2017.

Particle Measuring Systems (PMS). Particle Transportation. Particle Measuring Systems Application Note 201. 2018.

Rahaman MD, Kaiju H, Kawaguchi N, Ishibashi A. Ultra-High Cleanliness of ISO Class Minus 1 Measured in Triply Connected Clean-Unit System Platform. JJAP Vol. 4. 2008.

Rhoads R, Exner L, Wagner JT. Demystifying dynamic smoke pattern tests for sterile compounding pharmacies. AJHSP. 2020.

Rouaud O, Havet M. Computation of the airflow in a pilot scale clean room using K-↋ turbulence models. IJR. 2002.

Sekuloska H, Todorovski A, Petreska M. Trending environmental monitoring data, analysis and data management for non-sterile pharmaceutical manufacturing. Makedonsko Farmacevtski Bilten. 2022.

Serra JA, Domenech E, Escriche I, Martorell S. Risk assessment and critical control points from the production perspective. IJFM. 1999.

Shao X, Liu Y, Hao Y, Wen X, Li C, Ma X, et al. Smoke visualization for the invasion of pollutants during door-opening process in pharmaceutical cleanrooms: Effects of initial pressure differential and airlock barriers. Energy Buildings. 2022.

Sutton S. Qualification on an Environmental Monitoring Program. JVT. 2010.

Whyte W, Eaton T, Whyte WM, Lenegan N, Ward S, Agricola K. Calculation of air supply rates and concentrations of airborne contamination in non-UDAF cleanrooms. EJPPS. 2017.

Whyte W, Whyte WM, Ward S, Agricola K. Ventilation effectiveness in cleanrooms and its relation to decay rate, recovery rate, and air change rate. EJPPS. 2018.

Downloads

Published

2025-11-10

Data Availability Statement

Declaração ausente.

Issue

Section

Article

How to Cite

Continuous airborne particle count in the pharmaceutical industrial environment: a fundamentals theoretical review. (2025). Brazilian Journal of Pharmaceutical Sciences, 61, e24077. https://doi.org/10.1590/s2175-97902025e24077